Literature DB >> 18026887

[Patient-centred care in rare diseases. A patient organisations' perspective].

A Reimann1, J Bend, B Dembski.   

Abstract

Patients living with rare diseases have special common needs. Although the 5,000-6,000 rare diseases are very different, many patients share the experience of a time-consuming and sometimes frustrating journey towards diagnosis, the lack of established standards of care and foremost the search for competent physicians. Because of their complexity, rare diseases mostly demand an interdisciplinary and cross-sectional medical care. The model of the "patient-centred health-care value chain" explains how primary (prevention, diagnosis, treatment) and secondary activities (exchange of information, quality management, identification of unmet needs, research and development) contribute to the patient benefit applying a holistic approach. This model thereby prevents an isolated view from the perspective of single health-care providers. A survey to which 21 German patient-organisations in the rare-disease field contributed, was performed to obtain insight into preferred medical care concepts and preferences in the way that care is provided. The results clearly suggest that the patient organisations have a clear view on how disease-specific care should be delivered; however, in reality those preferences seem to be met to a minor extent in Germany at present. According to patient organisations, rare-disease patient care should always be a patient- centred, interdisciplinary and holistic effort. The solidaric health-care system in Germany provides an excellent basis for this kind of medical care. However, a new patient- rather than system-oriented approach is needed to make it work in reality.

Entities:  

Mesh:

Year:  2007        PMID: 18026887     DOI: 10.1007/s00103-007-0382-8

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  12 in total

1.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

Review 2.  Perceived Benefits and Facilitators and Barriers to Providing Psychosocial Interventions for Informal Caregivers of People with Rare Diseases: A Scoping Review.

Authors:  Danielle B Rice; Andrea Carboni-Jiménez; Mara Cañedo-Ayala; Kimberly A Turner; Matthew Chiovitti; Alexander W Levis; Brett D Thombs
Journal:  Patient       Date:  2020-10       Impact factor: 3.883

Review 3.  Perceived Benefits and Factors that Influence the Ability to Establish and Maintain Patient Support Groups in Rare Diseases: A Scoping Review.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Danielle B Rice; Alexander W Levis; Lorie A Kloda; Annett Körner; Brett D Thombs
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

Review 4.  [Identification of rare diseases in the oral cavity].

Authors:  Marcel Hanisch; Susanne Jung; Johannes Kleinheinz
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

Review 5.  Support Groups in Scleroderma.

Authors:  Danielle B Rice; Brett D Thombs
Journal:  Curr Rheumatol Rep       Date:  2019-02-21       Impact factor: 4.592

6.  Reasons for attending support groups and organizational preferences: A replication study using the North American Scleroderma Support Group Survey.

Authors:  Mia Pépin; Linda Kwakkenbos; Marie-Eve Carrier; Sandra Peláez; Ghassan El-Baalbaki; Vanessa L Malcarne; Brett D Thombs
Journal:  J Scleroderma Relat Disord       Date:  2019-05-29

7.  Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND): Study protocol.

Authors:  Marie-Eve Carrier; Linda Kwakkenbos; Isabelle Boutron; Joep Welling; Maureen Sauve; Cornelia van den Ende; Anne A Schouffoer; Marie Hudson; Brett D Thombs; Luc Mouthon
Journal:  J Scleroderma Relat Disord       Date:  2017-10-16

Review 8.  Effect of support group peer facilitator training programmes on peer facilitator and support group member outcomes: a systematic review.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Lorie A Kloda; Jill Boruff; Ghassan El-Baalbaki; Annett Körner; Vanessa L Malcarne; Brett D Thombs
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

9.  Rare Diseases with Periodontal Manifestations.

Authors:  Marcel Hanisch; Thomas Hoffmann; Lauren Bohner; Lale Hanisch; Korbinian Benz; Johannes Kleinheinz; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2019-03-09       Impact factor: 3.390

10.  The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.

Authors:  Linda Kwakkenbos; Lisa R Jewett; Murray Baron; Susan J Bartlett; Dan Furst; Karen Gottesman; Dinesh Khanna; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Serge Poiraudeau; Maureen Sauve; Warren R Nielson; Janet L Poole; Shervin Assassi; Isabelle Boutron; Carolyn Ells; Cornelia Hm van den Ende; Marie Hudson; Ann Impens; Annett Körner; Catarina Leite; Angela Costa Maia; Cindy Mendelson; Janet Pope; Russell J Steele; Maria E Suarez-Almazor; Sara Ahmed; Stephanie Coronado-Montoya; Vanessa C Delisle; Shadi Gholizadeh; Yeona Jang; Brooke Levis; Katherine Milette; Sarah D Mills; Ilya Razykov; Rina S Fox; Brett D Thombs
Journal:  BMJ Open       Date:  2013-08-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.